Navin Pandit

Development of MKI-3: A Potent and Selective MASTL Inhibitor with Improved Efficacy for Cancer Treatment

Jae‐Joong Kim, Ye-Hyun Kim, Navin Pandit, Kyu Myung Lee et autres

ye, kr, cz, cn (code pays fourni par la source)

Palladium‐Catalyzed Cascade for Rapid Access to Tetrahydro‐4H‐pyrazolo[3,4‐d]pyrrolo[1,2‐a]pyrimidin‐4‐one Tetracyclic Fused Heterocycles

Navin Pandit, Youyoung Kim, Kyu Myung Lee

kr (code pays fourni par la source)

Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma

Yuna Kim, Kwan‐Young Jung, Yun Hak Kim, Pan Xu et autres

kr, ch, be, by (code pays fourni par la source)

Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure–activity relationship study

Jung‐Hoon Kim, Navin Pandit, Miyoun Yoo, Tae Hyun Park et autres

kr, us (code pays fourni par la source)

Loss-of-SIRT7 sensitizes hepatocellular carcinoma to sorafenib through the regulation of ERK Phosphorylation

Yuna Kim, Kwan‐Young Jung, Pan Xu, Yunju Jo et autres

kr, ch, be, by (code pays fourni par la source)

Discovery of BET specific bromodomain inhibitors with a novel scaffold

Navin Pandit, Miyoun Yoo, Tae Hyun Park, Ji‐In Kim et autres

kr, us (code pays fourni par la source)

PCW-1001, a Novel Pyrazole Derivative, Exerts Antitumor and Radio-Sensitizing Activities in Breast Cancer

Minsung Kang, Navin Pandit, Ah-Young Kim, Suk Joon Cho et autres

kr (code pays fourni par la source)

Abstract B43: Novel small-molecule human STING agonists generate robust Type I interferon responses in tumors

Monali Banerjee, Sandip Middya, Sourav Basu, Ritesh Shrivastava et autres

gb (code pays fourni par la source)

Abstract 3510: Small molecule ACSS2 inhibitors target acetate metabolizing tumor cells in hypoxic conditions

Monali Banerjee, Sourav Basu, Debjani Chakraborty, Ritesh Shrivastava et autres